According to docking studies, coumarin complexes C1 and C2, exhibiting in vitro potent antiproliferative effect against pancreatic carcinoma cells, can interact with tyrosine kinase receptors. The gene discussed is NTRK1; the disease is exocrine pancreatic carcinoma.